BN vs IX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

BN is the larger of the two ($95.10B market cap): the incumbent the market prices for continued execution (7.26x forward earnings, beta 1.83). IX is the smaller challenger ($35.04B), cheaper on forward earnings (2.78x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

BN vs IX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricBNIXWhat it tells you
Market cap$95.10B$35.04BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E7.262.78Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E78.895.97Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.830.75Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range50% of range43% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book2.241.09How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: IX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how BN and IX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BN and IX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BN and IX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Brookfield Corporation (BN) do?

Brookfield Corporation sits at the top of the Brookfield group and reports through three pillars. Asset management runs through its roughly 73% interest in Brookfield Asset Management, whose fee-bearing capital reached a record ~$672 billion at the end of June 2026, up ~19% year over year, after record quarterly fundraising of ~$77 billion; Brookfield completed its acquisition of the rest of credit manager Oaktree in July 2026. Wealth solutions is the annuity, pension-risk-transfer and P&C insurance business (Brookfield Wealth Solutions, built from American National, Argo Group, American Equity Life and, since the 2026 acquisition, UK annuity provider Just Group) that gathers policyholder money and invests it alongside Brookfield's own funds; insurance assets reached ~$191 billion at mid-year, including ~$45 billion added by Just Group. The third pillar is the operating businesses, held partly through the listed affiliates: Brookfield Renewable (BEP/BEPC), Brookfield Infrastructure (BIP/BIPC), Brookfield Business Partners (BBU/BBUC) and a wholly owned real estate book that includes Canary Wharf, Brookfield Place and Ala Moana Center. Bruce Flatt has run the company since 2002, and the December 2022 reorganisation is what created the BN-versus-BAM split: BN kept the balance sheet and the carried interest, BAM was carved out as the pure-play, high-payout manager.

Full BN guide

What does ORIX Corporation (IX) do?

ORIX Corporation runs roughly ~JPY 18.3 trillion of assets across businesses most US investors would not expect under one roof. It leases equipment and vehicles in Japan, operates a bank and a life insurer, develops and trades real estate, runs airport concessions and renewable power plants, owns the Dutch asset manager Robeco with ~EUR 463 billion under management, and holds a large position in aircraft lessor Avolon. Group assets under management reached ~JPY 81 trillion in the June 2026 quarter against a stated ~JPY 100 trillion target for fiscal 2028. The company reports in Japanese yen on a fiscal year ending March 31, and one ADS has represented one common share since the depositary moved the ratio off five-to-one in February 2025, so IX tracks the Tokyo line (8591) almost exactly apart from the exchange rate (roughly ~JPY 159 per dollar when the June quarter was reported in August).

Full IX guide

BN vs IX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • BN drivers: Fee-bearing capital and carried interest at BAM; The insurance and annuity flywheel.
  • IX drivers: Fee income from asset management; Aircraft, ships and the transportation build-out.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. For IX, the clearest risk is earnings quality, because a large share of recent profit came from marking Kioxia rather than from operations, and management has said each ~JPY 10,000 move in that share price is worth roughly ~JPY 57 billion after tax in either direction.

BN or IX: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BN if you believe its drivers more; IX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BN and IX guides.

BN vs IX: the full fundamentals

BN. At ~$36.84 the shares trade at roughly 14 times trailing distributable earnings of ~$2.61 per share, cheaper than earlier in 2026 after a ~21% slide, while the reported P/E in the high 60s is not a like-for-like multiple: depreciation on infrastructure and the share of consolidated profit belonging to outside partners both sit between revenue and attributable earnings. Brookfield's own buybacks earlier in the year averaged ~$42, above the current price. Third quarter 2026 results are scheduled for November 12, 2026.

IX. ORIX reports in Japanese yen on a fiscal year ending March 31, so the dollar figures here are conversions at roughly ~JPY 159 to the dollar and shift with the exchange rate. Trailing earnings are flattered by the Kioxia gain, which means the ~10 times multiple understates what a normalized year looks like, and the company's own full-year forecast of ~JPY 530 billion implies a meaningfully higher multiple. Because one ADS equals one common share, IX and the Tokyo listing 8591 move together apart from currency, and the next earnings report lands on November 9, 2026.

Headline figures (approximate, October 2026): BN shows share price / market cap ~$36.84 per share, ~$82 billion (Oct 16, 2026 close), revenue (ttm) ~$81 billion, net income attributable (ttm) ~$1.4 billion, a reported P/E in the high 60s, distributable earnings (q2 2026) ~$1.5 billion, ~$0.66 per share (~$0.61 before realizations, up ~15%); IX shows market cap ~$40 billion (ADR at ~$37.09 on October 16, 2026), revenue (ttm) ~JPY 3.46 trillion (~$22 billion), up ~17% year on year in the latest quarter, net income (ttm) ~JPY 623 billion (~$3.9 billion), a ~18% profit margin, latest quarter (q1 fy2027, ended june 2026) ~JPY 281 billion net income (~$1.8 billion), up ~162% year on year.

The bottom line: BN vs IX

BN and IX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BN and IX exposure against your real portfolio. It is not an investment adviser.

Wondering how BN or IX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Brookfield Corporation

Ask Walnut's AI anything about BN and see how it fits what you own.

FAQ

What is the difference between BN and IX?

+

Brookfield Corporation sits at the top of the Brookfield group and reports through three pillars. ORIX Corporation runs roughly ~JPY 18.3 trillion of assets across businesses most US investors would not expect under one roof. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is BN or IX the better stock?

+

Neither is universally better. BN is the larger incumbent; IX is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, BN or IX?

+

On forward P/E (as of November 2026), BN trades at 7.26x and IX at 2.78x, so IX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both BN and IX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of BN vs IX?

+

BN: The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Leverage sits mostly at the asset level in non-recourse form (Yahoo shows ~$269 billion of consolidated debt), which limits contagion but leaves refinancing exposed to long rates and credit spreads across hundreds of separate structures. The office and retail real estate book has already required writedowns and remains the least liquid piece, though leasing improved in 2026. The insurance pillar, now larger after Just Group, introduces a different risk set entirely: spread compression if rates fall, reserve assumptions on long-dated annuities, and regulators in multiple jurisdictions reviewing private-capital ownership of annuity liabilities. Integrating Oaktree adds execution risk in credit. Carried interest and realization gains depend on exit markets that shut for long stretches, and BN's ~1.8 beta means the stock has historically fallen harder than the index when sentiment turns, as the ~21% decline in 2026 shows. IX: The clearest risk is earnings quality, because a large share of recent profit came from marking Kioxia rather than from operations, and management has said each ~JPY 10,000 move in that share price is worth roughly ~JPY 57 billion after tax in either direction. The November 9 report for the September quarter is where any reversal would first show. Guidance is awkward to read as well: the company guides ~JPY 840 billion of net income for the first half while leaving its full-year forecast at ~JPY 530 billion unchanged, a gap that reflects caution about mark-to-market reversals rather than an expected second-half loss. Leverage is real, with ~JPY 18.3 trillion of assets on ~JPY 4.7 trillion of equity for a ~25.8% equity ratio, total debt near ~JPY 6.3 trillion, and credit exposure running through Japanese real estate, US lending and aircraft. For a dollar-based holder the yen adds a second layer, since a weaker yen shrinks dollar returns even when the underlying business performs. A group spanning leasing, insurance, banking, energy, concessions and asset management also resists valuation on any single multiple, which is part of why the conglomerate discount has persisted for years. Analyst coverage of the ADR itself is thin, so published price targets carry little information.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BN or IX; figures are approximate and dated (as of November 2026). Verify current data before investing.